150 related articles for article (PubMed ID: 7475065)
1. Argyrophilic nucleolar organizer region (AgNOR) area per nucleus as a prognostic factor in breast cancer.
Nakayama K; Abe R
J Surg Oncol; 1995 Nov; 60(3):160-7. PubMed ID: 7475065
[TBL] [Abstract][Full Text] [Related]
2. Argyrophilic nucleolar organizer regions in breast carcinoma. Correlation with DNA flow cytometry, histopathology, and lymph node status.
Mourad WA; Erkman-Balis B; Livingston S; Shoukri M; Cox CE; Nicosia SV; Rowlands DT
Cancer; 1992 Apr; 69(7):1739-44. PubMed ID: 1312892
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of quantitatively measured AgNORs in ductal mammary carcinoma.
Aubele M; Auer G; Jütting U; Falkmer U; Gais P
Anal Quant Cytol Histol; 1994 Jun; 16(3):211-8. PubMed ID: 7522453
[TBL] [Abstract][Full Text] [Related]
5. Nucleolus organizer regions (AgNORs) in ductal mammary carcinoma. Comparison with classifications and prognosis.
Aubele M; Auer G; Gais P; Jütting U; Rodenacker K; Voss A
Pathol Res Pract; 1994 Feb; 190(2):129-37. PubMed ID: 7520163
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
[TBL] [Abstract][Full Text] [Related]
7. Silver-binding argyrophilic nucleolar organizer regions (AgNOR) in gall-bladder cancer: correlations with malignant grading and prognosis.
Suzuki T; Takano Y; Kida Y; Okudaira M
Acta Pathol Jpn; 1993; 43(1-2):36-43. PubMed ID: 8465655
[TBL] [Abstract][Full Text] [Related]
8. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
Pich A; Chiarle R; Chiusa L; Palestro G
Cancer; 1994 Sep; 74(5):1568-74. PubMed ID: 7520349
[TBL] [Abstract][Full Text] [Related]
9. Argyrophilic nucleolar organizer regions in breast cancer: prognostic significance.
Kolár Z; Zábranský T; Mattler K; Zábranský E
Cesk Patol; 1992 Sep; 28(4):193-200. PubMed ID: 1335841
[TBL] [Abstract][Full Text] [Related]
10. Argyrophilic nucleolar organizer regions, bromodeoxyuridine labelling index and DNA ploidy in squamous cell carcinoma of the uterine cervix.
Gasińska A; Zabagło L; Cichocka A; Pudełek J; Urbański K; Skołyszewski J
Folia Histochem Cytobiol; 1996; 34(2):95-101. PubMed ID: 8875218
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of AgNORs in breast cancer].
Aubele M; Auer G; Jütting U
Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of argyrophilic nucleolar organizer regions (AGNOR) in oesophageal cancer.
Babu M; Mathur M; Gupta SD; Chattopadhyay TK
Trop Gastroenterol; 1996; 17(1):57-60. PubMed ID: 8693588
[TBL] [Abstract][Full Text] [Related]
13. AgNORs in breast tumours.
Ceccarelli C; Trerè D; Santini D; Taffurelli M; Chieco P; Derenzini M
Micron; 2000 Apr; 31(2):143-9. PubMed ID: 10588060
[TBL] [Abstract][Full Text] [Related]
14. Morphometric determination of AgNORs in breast carcinoma. Correlation with flow cytometry and proliferating cell nuclear antigen.
Bellotti M; Elsner B; Kahn A; Bezodnick L; Pisilli L; Greco P
Anal Quant Cytol Histol; 1997 Apr; 19(2):139-44. PubMed ID: 9113306
[TBL] [Abstract][Full Text] [Related]
15. Argyrophilic nucleolar organizer regions: their value and correlation with clinical prognostic factors in breast carcinoma.
Kumar A; Kushwaha AK; Kumar M; Gupta S
J Surg Oncol; 1997 Jul; 65(3):201-4. PubMed ID: 9236930
[TBL] [Abstract][Full Text] [Related]
16. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Chiusa L; Galliano D; Formiconi A; Di Primio O; Pich A
Cancer; 1997 May; 79(10):1956-63. PubMed ID: 9149023
[TBL] [Abstract][Full Text] [Related]
17. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ
Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of argyrophilic nucleolar organizer regions in nasopharyngeal carcinoma.
Pak MW; To KF; Leung SF; van Hasselt CA
Eur Arch Otorhinolaryngol; 2000 Nov; 257(9):517-20. PubMed ID: 11131381
[TBL] [Abstract][Full Text] [Related]
19. Nuclear DNA content and nucleolar organizer regions in colorectal cancer.
Adachi Y; Kido A; Mori M; Matsushima T; Shimono R; Inoue T; Sugimachi K
J Surg Oncol; 1995 Jul; 59(3):177-80. PubMed ID: 7609524
[TBL] [Abstract][Full Text] [Related]
20. Argyrophilic nucleolar organizer regions in human adrenocortical neoplasms.
Kida Y; Takano Y; Okudaira M
J Cancer Res Clin Oncol; 1992; 119(1):49-54. PubMed ID: 1400566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
